基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 3,229.70
成立日期: 12/08/2005
 
分析
市值分佈:
19.46%
大市值
33.73%
中市值
47.10%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:05) 總持有投資項目: 1294  
0%
 
100%
     10大 (12.39%)
代號 名稱 佔比% 持有日期
NRIXNurix Therapeutics0.3229/04/2026
ELVNEnliven Therapeutics0.3229/04/2026
KODKodiak Sciences0.3229/04/2026
NESRNational Energy Services Reunited Corp0.3127/04/2026
DHCDiversified Healthcare Trust0.3127/04/2026
WTTRSelect Water Solutions0.3129/04/2026
EFCEllington Financial0.3129/04/2026
TILEInterface0.3129/04/2026
STOKStoke Therapeutics0.3129/04/2026
BBAIBigBearai Holdings0.3027/04/2026
ALMSAlumis Inc.0.3029/04/2026
AORTArtivion0.2929/04/2026
BFCBank First Corp0.2929/04/2026
PENGPenguin Solutions Inc0.2929/04/2026
QCRHQCR Holdings0.2829/04/2026
NVRIEnviri Corp0.2829/04/2026
OUSTOuster Inc0.2829/04/2026
AMLXAmylyx Pharmaceuticals0.2729/04/2026
ARLOArlo Technologies0.2729/04/2026
TPBTurning Point Brands0.2729/04/2026
  1    2   3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33    34    35    36    37    38    39    40    41    42    43    44    45    46    47    48    49    50    51    52    53    54    55    56    57    58    59    60    61    62    63    64    65  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.